Resatorvid

Resatorvid

SCHEMBL30113148

CCOC(=O)C1=CCCCC1S(=O)(=O)Nc1ccc(F)cc1Cl

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

TLR4

The experimentally established mechanism targets of Resatorvid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
TLR4 known ✓ O00206 9/20 1.00
MRGPRX1 Q96LB2 6/20 0.43
TSPO P30536 2/20 0.41
HRH1 P35367 1/20 0.41
KMT2A Q03164 1/20 0.41
LMNA P02545 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Resatorvid SCHEMBL29607069 1.00 TLR4 (1.00) TLR4MRGPRX1TSPOHRH1KMT2A
Resatorvid SCHEMBL871572 1.00 TLR4 (1.00) TLR4MRGPRX1TSPOHRH1KMT2A
Resatorvid SCHEMBL1821271 1.00 TLR4 (1.00) TLR4MRGPRX1TSPOHRH1KMT2A
Resatorvid SCHEMBL872197 1.00 TLR4 (1.00) TLR4MRGPRX1TSPOHRH1KMT2A
SCHEMBL871253 0.97 TLR4 (1.00) TLR4MRGPRX1TSPOHRH1KMT2A
SCHEMBL871685 0.94 TLR4 (1.00) TLR4MRGPRX1TSPOHRH1KMT2A
Resatorvid SCHEMBL13944442 0.90 TLR4 (0.82) TLR4MRGPRX1TSPOHRH1KMT2A
Resatorvid SCHEMBL13944682 0.90 TLR4 (0.82) TLR4MRGPRX1TSPOHRH1KMT2A
Resatorvid SCHEMBL13944518 0.90 TLR4 (0.82) TLR4MRGPRX1TSPOHRH1KMT2A
Resatorvid SCHEMBL13944446 0.90 TLR4 (0.85) TLR4MRGPRX1TSPOHRH1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4110368-A1 TREATMENT OF LIVER FAILURE Hepyx Limited (GB) 2023-01-04 EP disclosed